H0628R2988A05020 MSP:JSL 04/13/20 #90 A05020
AMENDMENTS TO HOUSE RESOLUTION NO. 628
Sponsor: REPRESENTATIVE DERMODY
Printer's No. 2988
Amend Resolution, page 1, line 3, by striking out the period
after "aids" and inserting
; and urging the Congress of the United States to approve the
Protecting Our Pharmaceutical Supply Chain From China Act,
which would ensure that the United States is not dependent on
foreign countries for pharmaceutical manufacturing.
Amend Resolution, page 3, line 7, by striking out "therefore
be it " and inserting
and
WHEREAS, Protecting the health and safety of Americans is the
primary job of elected officials at all times, but especially so
during the worldwide COVID-19 pandemic; and
WHEREAS, Domestic production of life-sustaining drugs and
medical equipment will ensure that these vital products meet the
stringent standards of the United States; and
WHEREAS, The United States Food and Drug Administration (FDA)
has warned that systemic problems at drug manufacturing
facilities overseas, particularly in China and India, have led
to tainted medication circulating in the United States; and
WHEREAS, The FDA estimates that roughly 85% of the facilities
that manufacture ingredients in American drugs are located
overseas; and
WHEREAS, In 2019, millions of Americans ingested a
contaminant formerly used in the production of rocket fuel
through tainted blood pressure drugs produced in China; and
WHEREAS, As much as 95% of ibuprofen, 70% of acetaminophen
and 45% of penicillin is made in China; and
WHEREAS, An over-reliance on foreign production of
pharmaceuticals affects the health of Americans and also the
health of America's economy; and
WHEREAS, The United States should not be dependent on foreign
countries to supply vital drugs during a global pandemic; and
WHEREAS, Lawmakers are worried about drug shortages amid the
COVID-19 outbreak and have taken action to aid American
manufacturers in reclaiming pharmaceutical production; and
WHEREAS, The Protecting Our Pharmaceutical Supply Chain From
2020/90MSP/HR0628A05020 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
China Act would phase in a ban on United States agencies
purchasing pharmaceuticals with active ingredients produced in
China; and
WHEREAS, The bill would increase transparency by requiring
the FDA to create a registry of all drugs and by requiring drug
companies to list active ingredients and their countries of
origin on labels; and
WHEREAS, The measure would provide crucial incentives to ramp
up United States manufacturing of pharmaceutical drugs and
medical devices; therefore be it
Amend Resolution, page 3, lines 12 through 14, by striking
out all of said lines and inserting
RESOLVED, That the House of Representatives of the
Commonwealth of Pennsylvania urge the Congress of the United
States to approve the Protecting Our Pharmaceutical Supply Chain
From China Act, which would ensure that the United States is not
dependent on foreign countries for pharmaceutical manufacturing;
and be it further
RESOLVED, That a copy of this resolution be transmitted to
the President of the United States, the presiding officers of
each house of Congress and to each member of Congress from
Pennsylvania.
2020/90MSP/HR0628A05020 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22